Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JINS HoldingsTSE:3046 -19.38%96 Altman Z-Score is 5.64 as of Jul. 14, 2026, which is 8% below its 10-year median of 6.13. GuruFocus rates TSE:3046 with a GF Score™ of 96/100 and a GF Value™ of 円6,930.31 (Modestly Undervalued). Among 809 Medical Devices & Instruments companies, JINS Holdings ranks better than 75.9% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Good Sign:
Altman Z-score of 7.29 is strong.
JINS Holdings has a Altman Z-Score of 5.64, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for JINS Holdings's Altman Z-Score or its related term are showing as below:
TSE:3046'
s Altman Z-Score Range Over the Past 10 Years
Min: 3.81 Med: 6.13 Max: 10.66
Current: 7.29
During the past 13 years, JINS Holdings's highest Altman Z-Score was 10.66. The lowest was 3.81. And the median was 6.13.
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
Altman Z-Score does not apply to financial companies.
JINS Holdings Altman Z-Score Related Terms
JINS Holdings Altman Z-Score Historical Data
* Premium members only.
The historical data trend for JINS Holdings's Altman Z-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:3046 vs ISRG, BDX, MDLN: Altman Z-Score Comparison
For the Medical Instruments & Supplies subindustry, JINS Holdings's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JINS Holdings Altman Z-Score vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, JINS Holdings's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where JINS Holdings's Altman Z-Score falls into.
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
JINS Holdings's Altman Z-Score for today is calculated with this formula:
Z
=
1.2
*
X1
+
1.4
*
X2
+
3.3
*
X3
+
0.6
*
X4
+
1.0
*
X5
=
1.2
*
0.0933
+
1.4
*
0.4816
+
3.3
*
0.1672
+
0.6
*
4.5141
+
1.0
*
1.5909
=
5.64
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
JINS Holdings (TSE:3046) has a Altman Z-Score of 5.64 as of Jul. 14, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on JINS Holdings and its competitors. This is near median its historical median of 6.13. Over the past decade, JINS Holdings' Altman Z-Score has ranged from 3.81 to 10.66. According to the industry distribution chart, JINS Holdings ranks #195 out of 809 companies in the Medical Devices & Instruments industry, placing it in the top 24.1%.
Is JINS Holdings' Altman Z-Score too high?
JINS Holdings' current Altman Z-Score of 5.64 is near median its 10-year median of 6.13. Over the past 10 years, this metric has ranged from a low of 3.81 to a high of 10.66. The Medical Devices & Instruments industry median Altman Z-Score is 3.02. JINS Holdings' value of 5.64 is 86.8% above this industry median. Based on the distribution chart, JINS Holdings ranks #195 out of 809 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, JINS Holdings has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JINS Holdings' Altman Z-Score compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, JINS Holdings ranks #195 out of 809 companies for Altman Z-Score. This places JINS Holdings in the top 24% of its industry — outperforming the majority of peers. The industry median Altman Z-Score is 3.02. JINS Holdings' value of 5.64 is 86.8% above this benchmark. Historically, JINS Holdings' own Altman Z-Score has ranged from 3.81 to 10.66 over the past decade. While the company's 10-year median is 6.13 vs. the industry median of 3.02, JINS Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Medical Devices & Instruments company?
The median Altman Z-Score among Medical Devices & Instruments companies is 3.02, based on 809 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JINS Holdings's current Altman Z-Score of 5.64 is 86.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on JINS Holdings and its competitors. For the Medical Devices & Instruments industry, the median Altman Z-Score is 3.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JINS Holdings's current Altman Z-Score is 5.64, which is near median its own 10-year median of 6.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JINS Holdings stock overvalued right now?
Based on GuruFocus' analysis, JINS Holdings (TSE:3046) is currently considered Modestly Undervalued. The stock's GF Value™ is 円6,930.31, compared to a current price of 円6,240.00 — trading 10% below its estimated fair value. The current Altman Z-Score is 5.64, which is near median its 10-year median of 6.13 and 86.8% above the Medical Devices & Instruments industry median of 3.02. JINS Holdings' overall GF Score™ is 96/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For JINS Holdings (TSE:3046), the current Altman Z-Score is 5.64 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JINS Holdings (TSE:3046) Overvalued in 2026?
Based on GuruFocus' analysis, JINS Holdings stock appears to be undervalued.
The current stock price of 円6,240.00 is trading 10% below its estimated GF Value™ of 円6,930.31.
GuruFocus considers JINS Holdings to be Modestly Undervalued.
Key valuation signals for TSE:3046:
Altman Z-Score: 5.64 (near median its 10-year median of 6.13)
GF Value™: 円6,930.31 vs. price of 円6,240.00 (10% below fair value)
Industry Position: 86.8% above the Medical Devices & Instruments median (#195 of 809)
No single metric tells the full story. See the TSE:3046 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JINS Holdings Inc is an eyewear retailer that manufactures and sells private-label fashion eyeglasses and sunglasses. It offers prescription eyeglasses and nonprescription fashion or functional eyeglasses. Its inventory is on the shelves, and it charges flat rates with generally no additional charges or options for lens features. Jin has more than 300 stores in Japan as well as locations in China, Taiwan, and the United States. Stores are typically located in high-traffic areas such as shopping centers, malls, and train stations.
96GF Score
Get the complete analysis for TSE:3046
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3046 has been successfully added to your 
